Price Alert

Agios Pharmaceuticals Inc... (AGIO)

NASDAQ: AGIO · Real-Time Price · USD

36.78

0.10 (0.27%)

At close: Aug 15, 2025, 12:01 PM

Agios Pharmaceuticals Statistics

Share Statistics

Agios Pharmaceuticals has 58.1M shares outstanding. The number of shares has increased by 1.8% in one year.

Shares Outstanding	58.1M
Shares Change (YoY)	1.8%
Shares Change (QoQ)	1.08%
Owned by Institutions (%)	99.99%
Shares Floating	55.56M
Failed to Deliver (FTD) Shares	51
FTD / Avg. Volume	0.01%

Short Selling Information

The latest short interest is 4.18M, so 7.22% of the outstanding shares have been sold short.

Short Interest	4.18M
Short % of Shares Out	7.22%
Short % of Float	7.27%
Short Ratio (days to cover)	5.86

Valuation Ratios

The PE ratio is 2.77 and the forward PE ratio is -4.97. Agios Pharmaceuticals's PEG ratio is -0.01.

PE Ratio	2.77
Forward PE	-4.97
PS Ratio	51.14
Forward PS	17.6
PB Ratio	1.21
P/FCF Ratio	-4.77
PEG Ratio	-0.01

Financial Ratio History

Enterprise Valuation

Agios Pharmaceuticals has an Enterprise Value (EV) of 1.85B.

EV / Sales	50.62
EV / EBITDA	-4.34
EV / EBIT	-4.74
EV / FCF	-4.72

Financial Position

The company has a current ratio of 11.9, with a Debt / Equity ratio of 0.04.

Current Ratio	11.9
Quick Ratio	11.56
Debt / Equity	0.04
Debt / EBITDA	-0.13
Debt / FCF	-0.15
Interest Coverage	0

Financial Efficiency

Return on Equity is 43.72% and Return on Invested Capital is -24.99%.

Return on Equity	43.72%
Return on Assets	40.51%
Return on Invested Capital	-24.99%
Revenue Per Employee	$75.1K
Profits Per Employee	$1.39M
Employee Count	486
Asset Turnover	0.02
Inventory Turnover	0.15

Taxes

Income Tax	44.24M
Effective Tax Rate	6.16%

Stock Price Statistics

The stock price has increased by -21.55% in the last 52 weeks. The beta is 0.8, so Agios Pharmaceuticals's price volatility has been higher than the market average.

Beta	0.8
52-Week Price Change	-21.55%
50-Day Moving Average	36.09
200-Day Moving Average	36.74
Relative Strength Index (RSI)	44.05
Average Volume (20 Days)	751,953

Income Statement

In the last 12 months, Agios Pharmaceuticals had revenue of 36.5M and earned 673.73M in profits. Earnings per share was 11.86.

Revenue	36.5M
Gross Profit	32.33M
Operating Income	-425.74M
Net Income	673.73M
EBITDA	-425.74M
EBIT	-425.74M
Earnings Per Share (EPS)	11.86

Full Income Statement

Balance Sheet

The company has 76.25M in cash and 56.99M in debt, giving a net cash position of 19.26M.

Cash & Cash Equivalents	76.25M
Total Debt	56.99M
Net Cash	19.26M
Retained Earnings	-148.92M
Total Assets	1.47B
Working Capital	949.05M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -389.84M and capital expenditures -1.69M, giving a free cash flow of -391.53M.

Operating Cash Flow	-389.84M
Capital Expenditures	-1.69M
Free Cash Flow	-391.53M
FCF Per Share	-6.89

Full Cash Flow Statement

Margins

Gross margin is 88.59%, with operating and profit margins of -1166.47% and 1845.92%.

Gross Margin	88.59%
Operating Margin	-1166.47%
Pretax Margin	1967.15%
Profit Margin	1845.92%
EBITDA Margin	-1166.47%
EBIT Margin	-1166.47%
FCF Margin	-1072.73%

Dividends & Yields

AGIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Payout Ratio	n/a
Earnings Yield	36.09%
FCF Yield	-20.97%

Dividend Details

Analyst Forecast

The average price target for AGIO is $55.5, which is 58.1% higher than the current price. The consensus rating is "Buy".

Price Target	$55.5
Price Target Difference	58.1%
Analyst Consensus	Buy
Analyst Count	8

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	85.08
Graham Upside	142.39%

Scores

Altman Z-Score	11.72
Piotroski F-Score	5